Week's top
Latest news
Unread news
Subscribe

Science X Account

Sign in with

Forget Password?

Not a member? Sign up

Allergy and immunology
Anesthesiology
Cardiology
Clinical genetics
Critical care medicine
Dermatology
Diagnostic radiology
Emergency medicine
Endocrinology
Family medicine
Gastroenterology
General surgery

Geriatric palliative care
Preventive medicine
Hospital medicine
Infectious diseases
Nephrology
Neurology
Obstetrics & gynecology
Oncology
Ophthalmology
Orthopedics
Pediatrics
Physiatry

Psychiatry
Pulmonary medicine
Rheumatology
Sleep medicine
Urology
Dentistry
Allied health
Occupational medicine
Sports medicine
Clinical pharmacology
Laboratory medicine

Healthy living
Nutrition & Healthy eating
Weight management
Fitness & Physical activity

Sleep & Recovery
Psychology & Mental health
Women's health
Men's health

Children's health
Healthy aging
Skin & Hair care
Common illnesses & Prevention

Digestive health
Reproductive health
Pregnancy
HIV & AIDS

Amblyopia
Antisocial Personality Disorder
Borderline Personality Disorder
Bronchitis
Carpal Tunnel Syndrome
Chickenpox
Chikungunya
Cholangiocarcinoma
Death
Developmental Disabilities
Diabetic Neuropathies
Dyslexia

Dyssomnias
Endolymphatic Hydrops
Eosinophilic Esophagitis
Gastroparesis
Hair Loss
Head and neck squamous cell carcinoma
Hemophilia A
Hepatitis A
Hyponatremia
Lassa Fever
Liver Cancer
Low Blood Pressure

Muscular Atrophy
Neoplasm, Residual
Neural Tube Defects
Noncommunicable Diseases
Otitis Media
Paralysis
Peptic Ulcer
Pregnancy Complications
Premenstrual Syndrome
Proteinuria
Rare Diseases
REM Sleep Behavior Disorder

Rubella
Sarcoma
Stomach Cancer
Sunburn
Tauopathies
Testicular Neoplasms
Tourette Syndrome
Valley Fever
Vertigo
Vitiligo
Wounds, Gunshot
Browse all »

Home
Archive
02/07/2026

Archive: 02/07/2026

FDA approves Tzield for children with new stage 3 type 1 diabetes

The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage ...

Jul 2, 2026

0

2

Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM

For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with more meaningful reductions in hemoglobin A1C (HbA1c) levels than semaglutide, according to a study ...

Jul 2, 2026

0

3

New drug unlocks elusive immune receptor, opening path toward motor neuron disease treatments

University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor—a breakthrough that could lead to new treatments for neurodegenerative conditions like motor neuron disease (MND).

Jul 2, 2026

0

8

EHA: Adding Pirtobrutinib to Venetoclax-Rituximab ups progression-free survival in chronic lymphocytic leukemia

For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according ...

Jul 2, 2026

0

2

Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.

Jul 2, 2026

0

4

Hybrid work improves the work experience—particularly for women

The transition to hybrid work has improved the psychosocial work environment among white-collar employees, according to new research from Umeå University. Positive effects include more accessible leadership, greater autonomy ...

Jul 2, 2026

0

4

Researchers call for increased screening for parasitic disease linked to HIV and cervical cancer risk

New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic ...

Jul 2, 2026

0

5

Two prostate cancer mutations reveal opposite responses to ferroptosis therapy

A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, ...

Jul 2, 2026

0

5

Precision fMRI maps prefrontal cortex in individuals, revealing fine-scale structures

Much like camera settings—filters, flashes and focus—affect what we notice in a final photo, the way scientists measure something can affect how we interpret and understand it. This is especially true when imaging things ...

Jul 2, 2026

0

7

FDA lets 20 ZYN nicotine pouches claim lower risk than cigarettes; critics warn of danger

The U.S. Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer advocates worried about ...

Jul 2, 2026

0

3

page 2 from 7

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Support us
Science X Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2026 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us